NRSN   $0.89  -3.26% Market Closed After Close 0.9 1.12%

Neurosense Therapeutics Ltd

EMA (20): 2024-11-15 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2024-11-18 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2024-11-19 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: entry into the oversold zone.

Trend Type turning down
Power almost flat
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -26.98%
EMA (20) date of signal Nov. 15, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -22.03%
EMA (50) date of signal Nov. 18, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -17.49%
EMA (100) date of signal Nov. 19, 2024, 3 a.m.
RSI Signals bearish
RSI (14) Yield -22.03%
RSI (14) date of signal Nov. 18, 2024, 3 a.m.
MACD Signals bearish
MACD Yield -7.07%
MACD date of signal Nov. 20, 2024, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -17.49%
Stochastic date of signal Nov. 19, 2024, 3 a.m.
Updated Nov. 22, 2024, 11:03 p.m.